Latin American experience with two low–dose oral contraceptives containing 30 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrel

S Bassol, A Alvarado, C Celis, MC Cravioto, O Peralta… - Contraception, 2000 - Elsevier
The objective of this study was to compare cycle control, efficacy and tolerance of an oral
contraceptive containing 20 μg ethinylestradiol and 150 μg desogestrel with a preparation …

Comparative study on the acceptability of two modern monophasic oral contraceptive preparations: 30 μg ethinyl estradiol combined with 150 μg desogestrel or 75 μg …

L Zichella, C Sbrignadello, A Tomassini… - Advances in …, 1999 - Springer
Cycle control and tolerability of two monophasic oral contraceptive pills containing 30 μg
ethinyl estradiol (EE) with either 150 μg desogestrel (DSG) or 75 μg gestodene (GSD) were …

Analysis of compliance with oral contraception in Spain

JJ Parrilla, C Coll, JM Bajo, J Balasch… - … European Journal of …, 1996 - Taylor & Francis
Objective The study was designed to analyze factors related to compliance in oral hormonal
contraception in Spain. Method A review study and a multicenter analysis of experience of …

A 13-month multicenter clinical experience of a low-dose monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene in Latin American …

S Bassol, G Alvarado, RG Arreola, C Celis-Gonzalez… - Contraception, 2003 - Elsevier
This prospective, multicenter study was conducted to evaluate the contraceptive reliability,
cycle control and tolerability of a 21-day oral contraceptive regimen containing 20 μg …

Preparation and in vitro/in vivo evaluation of gestodene (GEST) intravaginal ring.

C Li, M Ning, X Yao, Y Wang… - Pakistan Journal of …, 2016 - search.ebscohost.com
Preparation and in vitro/in vivo evaluation of gestodene (GEST) intravaginal ring (IVR)
formulations which can release a constant dose of GEST during 3 weeks were investigated …

A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene-and monophasic desogestrel-containing oral contraceptives

P Lacante - Gynecological Endocrinology, 1996 - Taylor & Francis
This was an open-label, multicenter study to compare the cycle control and effect on well-
being of two gestodene-containing and one desogestrel-containing oral contraceptive …

[PDF][PDF] O efeito da suspensão dos anticoncepcionais orais combinados sobre a pressão arterial em mulheres hipertensas

JN Lubianca - 2003 - lume.ufrgs.br
Em 1960, o primeiro anticoncepcional oral–Enovid®–foi aprovado para uso nos Estados
Unidos (1). A partir de então, inúmeras preparações, contendo diferentes dosagens, novos …

Avaliação da tolerabilidade e do controle de ciclo de dois contraceptivos orais de baixa dose: estudo comparativo aberto

EC Baracat, IC Barbosa, AA Campos… - Revista Brasileira de …, 1998 - SciELO Brasil
Realizou-se um estudo aberto comparativo em nove centros brasileiros para avaliar a
tolerabilidade e o controle de ciclo obtido com o uso de dois contraceptivos orais de baixa …

Multicenter evaluation of a new low-dose triphasic oral contraceptive containing ethinylestradiol and gestodene (Tri-Minulet®), and its effect on the quality of life

UJ Gaspard, P Lacante - Gynecological Endocrinology, 1996 - Taylor & Francis
To evaluate the effect of a low-dose, triphasic oral contraceptive containing gestodene and
ethinylestradiol (Tri-Minulet®) on the subjective quality of life and general well-being of …

Evaluation of the efficacy, tolerability and cycle control of a monophasic oral contraceptive containing gestodene and ethinylestradiol (Minulet®) in women over 35 …

RP Andrade, LF Aguiar, JM Aldrighi… - Gynecological …, 1996 - Taylor & Francis
The efficacy, tolerability and cycle control of a monophasic oral contraceptive preparation
containing gestodene (75μg) plus ethinylestradiol (30 μg)(Minulet®) were studied in 139 …